NHP6A Antibody

What is NHP6A and why would researchers need antibodies against it?

NHP6A is a small chromatin architectural protein containing a single HMGB domain that binds DNA in the minor groove and a basic N-terminal extension that wraps around DNA to contact the major groove . It is functionally related to mammalian HMGB1/2 proteins. Researchers need NHP6A antibodies for several reasons:

• To detect and study NHP6A in chromatin immunoprecipitation (ChIP) assays

• To visualize NHP6A localization via immunofluorescence microscopy

• To identify NHP6A-containing protein complexes via co-immunoprecipitation

• To perform supershift assays in electrophoretic mobility shift assays (EMSAs)

• To analyze NHP6A expression levels in different conditions

As demonstrated in research, anti-his antibodies have been successfully used to supershift NHP6A-DNA complexes in mobility shift assays .

How do NHP6A and NHP6B differ, and how can antibodies distinguish between them?

NHP6A and NHP6B are paralogous proteins in yeast with highly similar structures and largely redundant functions. Key considerations include:

• Both proteins contribute to genome stability and transcriptional regulation

• Single deletions of either gene produce mild phenotypes, while double deletion causes severe defects

• Both proteins function in RNA polymerase II and III transcription

• Distinguishing between them requires antibodies targeting unique epitopes

For experimental specificity:

• Use epitope-tagged versions (His-tagged NHP6A) when possible

• Validate antibody specificity against recombinant proteins

• Perform control experiments in single and double deletion strains

• Consider complementation assays to confirm specificity

What are optimal fixation conditions for NHP6A immunodetection?

For effective NHP6A detection in fixed samples:

• For ChIP applications: 1% formaldehyde for 15-20 minutes at room temperature offers optimal crosslinking while preserving antibody epitopes

• For immunofluorescence: 4% paraformaldehyde for 15 minutes followed by permeabilization with 0.1% Triton X-100

• Excessive fixation can mask epitopes, while insufficient fixation may fail to preserve protein-DNA interactions

• Consider that NHP6A's small size (approximately 11 kDa) and DNA-binding properties may affect epitope accessibility

These recommendations are based on standard protocols for DNA-binding proteins similar to NHP6A, though optimization may be necessary depending on experimental conditions.

What controls should be included when using NHP6A antibodies?

Robust experimental design requires multiple controls:

When using His-tagged NHP6A, anti-His antibodies can be used to confirm the presence of NHP6A in protein-DNA complexes .

How can NHP6A antibodies be used in electrophoretic mobility shift assays (EMSAs)?

NHP6A antibodies are valuable tools in EMSA studies to confirm protein identity in DNA-binding complexes:

• For supershift assays: Add 1-2 μg of NHP6A-specific antibody after the DNA-protein binding reaction but before loading onto the gel

• Optimal incubation: 20-30 minutes at room temperature after DNA-protein complex formation

• Buffer considerations: Ensure antibody buffer components don't interfere with DNA-protein interactions

• Controls: Include both anti-His antibodies (for tagged NHP6A) and anti-MSH6 antibodies as controls

As demonstrated in published research, anti-his antibodies effectively supershift his-tagged NHP6A bound to DNA, while anti-MSH6 antibodies do not affect the NHP6A-DNA complex, confirming complex specificity .

What methodological approaches help investigate NHP6A's role in DNA repair pathways?

To study NHP6A's involvement in DNA repair using antibodies:

• ChIP-based approaches:

  • Perform ChIP after DNA damage induction (UV or chemical agents)

  • Monitor NHP6A recruitment to damaged sites over time

  • Co-immunoprecipitate with repair factors like MSH2-MSH6

• Immunofluorescence co-localization:

  • Visualize NHP6A localization relative to repair factors

  • Monitor kinetics of recruitment following DNA damage

• Protein-protein interaction studies:

  • Co-immunoprecipitate NHP6A with repair factors like MSH2-MSH6

  • Validate interactions with proximity ligation assays

• Functional assays:

  • Compare repair efficiency in wildtype versus nhp6A∆ nhp6B∆ strains

  • Use antibodies to deplete NHP6A from in vitro repair assays

Research has shown that NHP6A can coexist with MSH2-MSH6 in complexes on mismatched DNA, and these complexes respond to ATP, suggesting a functional role in DNA repair processes .

How can researchers optimize ChIP protocols specifically for NHP6A?

NHP6A ChIP requires special considerations due to its small size and DNA-binding properties:

• Crosslinking optimization:

  • Standard 1% formaldehyde for 15 minutes may be insufficient

  • Consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde

  • Test both native and crosslinking ChIP approaches

• Sonication parameters:

  • Aim for 200-300bp fragments

  • Use gentler sonication to preserve protein-DNA complexes

  • Monitor sonication efficiency by gel electrophoresis

• Antibody selection and validation:

  • Validate antibody specificity using nhp6A∆ strains

  • Consider epitope-tagged versions when possible

  • Use multiple antibodies targeting different epitopes for confirmation

• Washing stringency:

  • Balance between background reduction and signal preservation

  • Test washing buffers with different salt concentrations

  • Consider detergent concentrations carefully

• Data analysis:

  • Compare binding profiles to transcription factors and chromatin remodelers

  • Analyze both sequence-specific and structural binding patterns

  • Correlate binding with gene expression changes in nhp6A∆ nhp6B∆ strains

What experimental approaches can identify NHP6A interaction partners in chromatin remodeling complexes?

To investigate NHP6A's interactions with chromatin remodeling complexes:

• Immunoprecipitation coupled with mass spectrometry:

  • Use crosslinking to capture transient interactions

  • Include DNase treatment to distinguish DNA-mediated from direct protein interactions

  • Compare interactions in different transcriptional states

• Proximity-based labeling:

  • Generate NHP6A fusions with BioID or APEX2

  • Identify proximal proteins via streptavidin pulldown and mass spectrometry

  • Compare labeling patterns in different genomic contexts

• Two-hybrid or split-reporter assays:

  • Screen for direct interactions with remodeling complex components

  • Validate interactions via co-immunoprecipitation

  • Map interaction domains through truncation constructs

• In vitro reconstitution:

  • Purify components and test direct interactions

  • Analyze how NHP6A affects remodeling activity of complexes like FACT

  • Monitor nucleosome dynamics in the presence/absence of NHP6A

Research has demonstrated that NHP6A allows Spt16-Pob3 (FACT complex) to bind to and reorganize nucleosomes in vitro, suggesting a key role in facilitating chromatin remodeling .

How can researchers optimize immunofluorescence protocols for detecting NHP6A in yeast cells?

Immunofluorescence detection of NHP6A in yeast requires specialized approaches:

• Cell wall digestion optimization:

  • Use zymolyase (100T at 0.5-1 mg/ml) for 30-60 minutes

  • Monitor spheroplast formation microscopically

  • Excessive digestion can disrupt nuclear architecture

• Fixation protocol:

  • 4% paraformaldehyde for 15-30 minutes

  • Alternative: 3.7% formaldehyde + 0.2% glutaraldehyde for tighter fixation

  • Test methanol fixation if paraformaldehyde masks epitopes

• Permeabilization:

  • 0.1% Triton X-100 for 5-10 minutes

  • Alternative: 0.5% NP-40 for more gentle permeabilization

  • Test digitonin for selective membrane permeabilization

• Blocking and antibody dilutions:

  • Extended blocking (2+ hours) with 3-5% BSA or normal serum

  • Higher primary antibody concentrations than typically used

  • Longer incubation times (overnight at 4°C)

• Nuclear counterstaining:

  • DAPI for total DNA visualization

  • Consider counterstains for nuclear structures (nucleolus, etc.)

  • Use Z-stack imaging to capture the full nuclear volume

What methods can determine if NHP6A is post-translationally modified under different conditions?

To analyze NHP6A post-translational modifications (PTMs):

• Antibody-based detection:

  • Use modification-specific antibodies (phospho-, acetyl-, etc.)

  • Validate with recombinant modified protein or peptides

  • Compare signals across different conditions

• Mass spectrometry approaches:

  • Immunoprecipitate NHP6A and analyze by LC-MS/MS

  • Enrich for specific modifications using IMAC (phosphorylation) or affinity resins

  • Quantify modification stoichiometry using stable isotope labeling

• Gel-based detection:

  • Observe mobility shifts on high-resolution gels

  • Confirm with phosphatase/deacetylase treatments

  • Use Phos-tag or similar technologies for phosphorylation detection

• Functional studies:

  • Mutate potential modification sites to non-modifiable residues

  • Test effects on DNA binding and protein interactions

  • Correlate modifications with functional outcomes

How can antibodies help elucidate the mechanism by which NHP6A affects transcriptional regulation?

To investigate NHP6A's role in transcription:

• ChIP-seq analysis:

  • Map genome-wide NHP6A binding sites

  • Compare with transcription factors and RNA polymerase occupancy

  • Analyze data from wildtype and nhp6A∆ nhp6B∆ strains

• Transcriptional reporter assays:

  • Use antibodies to deplete NHP6A from in vitro transcription systems

  • Compare transcription efficiency and start site selection

  • Add back purified protein to restore activity

• Protein complex analysis:

  • Immunoprecipitate NHP6A to identify associated transcription factors

  • Perform sequential ChIP (ChIP-reChIP) to identify co-occupancy

  • Use proximity labeling to identify transient interactions

• Functional domain mapping:

  • Generate truncation or point mutants

  • Test effects on transcription in vivo and in vitro

  • Use domain-specific antibodies to monitor different functions

Research has shown that NHP6A/B are required for efficient transcription of the SNR6 gene, with NHP6B specifically stimulating transcription up to fivefold in transcription assays . Additionally, NHP6A/B proteins function in repression and activation of various genes, suggesting a role in recruiting or stabilizing interactions of transcription factors with cognate sequences .

What approaches can determine how NHP6A and MSH2-MSH6 interact during DNA mismatch recognition?

To study NHP6A's interaction with mismatch repair proteins:

• In vitro binding studies:

  • EMSA with purified components

  • Antibody supershift assays to confirm complex components

  • Order-of-addition experiments to determine binding dynamics

• ATP-dependent complex analysis:

  • Monitor complex stability before and after ATP addition

  • Use non-hydrolyzable ATP analogs to trap intermediate states

  • Track protein retention on DNA after ATP addition

• DNA structure requirements:

  • Compare binding to homoduplex vs. heteroduplex DNA

  • Test different mismatch types and sequence contexts

  • Analyze binding to artificial DNA structures

• Protein-protein interaction mapping:

  • Co-immunoprecipitation with various truncation constructs

  • Crosslinking coupled with mass spectrometry

  • FRET-based interaction analysis in reconstituted systems

Research has shown that NHP6A binding to homoduplex DNA blocks MSH2-MSH6 binding, but does not affect MSH2-MSH6 binding to mismatches. Instead, NHP6A reduces MSH2-MSH6 nonspecific binding and forms a stable NHP6A-MSH2-MSH6-mismatched DNA complex, as confirmed by supershift assays with specific antibodies .

How can NHP6A antibodies be used to study engineered DNA architectural proteins?

For research involving engineered NHP6A fusion proteins:

• Expression validation:

  • Use antibodies to confirm expression levels of fusion constructs

  • Compare with endogenous NHP6A expression

  • Verify correct subcellular localization

• Functional domain analysis:

  • Generate antibodies against specific domains

  • Test accessibility of domains in fusion proteins

  • Monitor domain-specific functions in various contexts

• DNA binding characterization:

  • Use antibodies in ChIP to map genomic binding sites

  • Compare binding patterns of native and engineered proteins

  • Correlate with DNA structural changes

• Protein-protein interaction networks:

  • Identify novel interactions formed by fusion proteins

  • Compare with interaction networks of native protein

  • Map changes in complex formation

Recent research has explored fusion of NHP6A to sequence-specific DNA-binding proteins to create novel architectural DNA binding proteins that can alter DNA looping energetics, demonstrating their potential in synthetic biology applications .

What considerations are important when developing new NHP6A antibodies for specific research applications?

When developing new NHP6A antibodies:

• Epitope selection strategy:

  • Target unique regions to distinguish from NHP6B

  • Avoid DNA-binding domains if detecting DNA-bound protein

  • Consider accessibility in native protein conformation

• Antibody format considerations:

  • Full IgG for precipitation applications

  • Fab fragments for better penetration in dense chromatin

  • camelid nanobodies for minimal steric hindrance

• Validation requirements:

  • Test in wildtype, nhp6A∆, and nhp6B∆ strains

  • Validate with recombinant protein and in cellular contexts

  • Perform epitope mapping to confirm binding site

• Application-specific optimization:

  • ChIP-optimized antibodies may require different epitopes than Western blot antibodies

  • Consider post-translational modification status of target epitope

  • Test fixation compatibility for immunofluorescence applications